| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Real property rental revenue | NaN | NaN | 350,099 | 350,406 |
| Real property operating expenses | NaN | NaN | 234,366 | 251,077 |
| Real property operating income | NaN | NaN | 115,733 | 99,329 |
| Income (loss) from equity method investment - lab services mso | NaN | 0 | 0 | 0 |
| Credit loss recovery | NaN | NaN | -1,650,000 | 1,650,000 |
| Advertising and marketing expenses | 209,846 | 200,774 | 249,021 | 322,552 |
| Professional fees | 1,581,951 | 838,133 | 1,248,482 | 1,476,013 |
| Compensation and related benefits | 223,416 | 206,743 | 230,384 | 324,027 |
| Amortization of intangible assets | 563,000 | NaN | NaN | NaN |
| Other general and administrative expenses | 142,913 | 290,282 | 114,039 | 214,724 |
| Total other operating expenses | 2,721,126 | 1,535,932 | 191,926 | 3,987,316 |
| Loss from operations | -2,721,126 | -1,820,404 | -76,193 | -3,887,987 |
| Interest expense - amortization of debt discount and debt issuance costs | 189,417 | -18,898 | 31,339 | 810,409 |
| Interest expense - other | 82,029 | -409,498 | 236,069 | 247,255 |
| Interest expense - related party | NaN | NaN | 0 | 0 |
| Gain on extinguishment of debt | NaN | 34,291.5* | 0 | -9,076,587 |
| Change in fair value of derivative liability | 1,276,889 | -66,267 | -25,130 | -561,176 |
| Other expense | -107,219 | -32,446.5* | 64,203 | 2,464 |
| Total other expense | -1,655,554 | 496,508 | -178,075 | -9,570,611 |
| Loss before income taxes | -4,376,680 | -1,323,896 | -254,268 | -13,458,598 |
| Income taxes | NaN | NaN | 0 | 0 |
| Net loss from discontinued operations | -103,015 | -742,103 | NaN | NaN |
| Net loss | -4,479,695 | -2,065,999 | -254,268 | -13,458,598 |
| Less net loss attributable to noncontrolling interest | NaN | NaN | 0 | 0 |
| Net loss after noncontrolling interest | -4,479,695 | -2,065,999 | -254,268 | -13,458,598 |
| Less net loss attributable to noncontrolling interest | NaN | NaN | 0 | 0 |
| Deemed contribution on exchange of equity instruments | NaN | 0 | 0 | 0 |
| Net loss attributable to avalon globocare corp. common shareholders | -4,479,695 | -2,065,999 | -254,268 | -13,458,598 |
| Basic EPS | -0.5 | -0.643 | -0.06 | -6.22 |
| Diluted EPS | -0.5 | -0.643 | -0.06 | -6.22 |
| Basic Average Shares | 8,963,998 | 3,210,779* | 4,069,301 | 2,162,323 |
| Diluted Average Shares | 8,963,998 | 3,210,779* | 4,069,301 | 2,162,323 |
Avalon GloboCare Corp. (ALBT)
Avalon GloboCare Corp. (ALBT)